Muscular degeneration in the absence of dystrophin is a calcium-dependent process

被引:48
作者
Mariol, MC [1 ]
Ségalat, L [1 ]
机构
[1] Univ Lyon 1, CNRS, CGMC, UMR 5534, F-69622 Villeurbanne, France
关键词
D O I
10.1016/S0960-9822(01)00528-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Duchenne muscular dystrophy (DMD) is a progressive degenerative muscular disease that is due to mutations in the dystrophin gene [1]. Neither the function of dystrophin nor the physiopathology of the disease have been clearly established yet. Several groups have reported elevated calcium concentrations in the mdx mouse model of DMD, but the effect of calcium levels on the progression of the disease continues to be a matter of debate [2-4]. Here, we show that, in Caenorhabditis elegans, a gain-of-function mutation in the egl-19 calcium channel gene dramatically increases muscle degeneration in dystrophin mutants. Conversely, RNAi-mediated inhibition of egl-19 function reduces muscle degeneration by half. Therefore, our results demonstrate that calcium channel activity is a critical factor in the progression of dystrophin-dependent muscle degeneration.
引用
收藏
页码:1691 / 1694
页数:4
相关论文
共 18 条
[1]   THE STRUCTURAL AND FUNCTIONAL DIVERSITY OF DYSTROPHIN [J].
AHN, AH ;
KUNKEL, LM .
NATURE GENETICS, 1993, 3 (04) :283-291
[2]   How calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes [J].
Alderton, JM ;
Steinhardt, RA .
TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (06) :268-272
[3]   Mutations in the Caenorhabditis elegans dystrophin-like gene dys-1 lead to hyperactivity and suggest a link with cholinergic transmission [J].
Bessou, C ;
Giugia, JB ;
Franks, CJ ;
Holden-Dye, L ;
Ségalat, L .
NEUROGENETICS, 1998, 2 (01) :61-72
[4]   Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex [J].
Cohn, RD ;
Durbeej, M ;
Moore, SA ;
Coral-Vazquez, R ;
Prouty, S ;
Campbell, KP .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (02) :R1-R7
[5]  
Dubowitz V, 2000, J ROY COLL PHYS LOND, V34, P464
[6]   Functional genomic analysis of C-elegans chromosome I by systematic RNA interference [J].
Fraser, AG ;
Kamath, RS ;
Zipperlen, P ;
Martinez-Campos, M ;
Sohrmann, M ;
Ahringer, J .
NATURE, 2000, 408 (6810) :325-330
[7]   Genetic suppression of phenotypes arising from mutations in dystrophin-related genes in Caenorhabditis elegans [J].
Gieseler, K ;
Grisoni, K ;
Ségalat, L .
CURRENT BIOLOGY, 2000, 10 (18) :1092-1097
[8]   Molecular, genetic and physiological characterisation of dystrobrevin-like (dyb-1) mutants of Caenorhabditis elegans [J].
Gieseler, K ;
Mariol, MC ;
Bessou, C ;
Migaud, M ;
Franks, CJ ;
Holden-Dye, L ;
Ségalat, L .
JOURNAL OF MOLECULAR BIOLOGY, 2001, 307 (01) :107-117
[9]   Understanding dystrophinopathies:: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse [J].
Gillis, JM .
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 1999, 20 (07) :605-625
[10]  
Harfe BD, 1998, DEVELOPMENT, V125, P2479